AFIAS Total Anti-Infliximab test detects the total (free and bound) antibody against infliximab with a small amount of human serum or plasma in less than half an hour. This test provides information regarding the patients’ response towards the treatment of drug and based on result physicians can decide the appropriate infliximab regimen.
